D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: No association with phenotype or severity of phenotype

Neuropsychopharmacology

Volumn 20, Issue 6, 1999, Pages 640-649

  Gelernter, J ^a,b   Kranzler, H ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholism; Candidate genes; DRD2; Genetic association; Haplotypes; Promoter; Substance dependence; TaqI 'A' system

Indexed keywords

DOPAMINE 2 RECEPTOR;

ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ALLELE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPE;

ALCOHOLISM; ALLELES; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; PHENOTYPE; RECEPTORS, DOPAMINE D2;

EID: 0033137333     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00110-9     Document Type: Article

References (48)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd ed:1987;American Psychiatric Press, Washington, DC. a.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1987;American Psychiatric Press, Washington, DC. b.
3. Arinami T., Gao M., Hamaguchi H., Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet. 6:1997;577-582.
4. Blouin A.G., Perez E.L., Blouin J.H. Computerized administration of the Diagnostic Interview Schedule. Psychiatry Res. 23:1988;335-344.
5. Blum K., Noble E.P., Sheridan P.J., Montgomery A., Ritchie T., Jagadeeswaran P., Nogami H., Briggs A.H., Cohn J.B. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA. 263:1990;2055-2060.
6. Blum K., Sheridan P.J., Chen T.C.H., Wood R.C., Braverman E.R., Cull J.G., Comings D.E. The dopamine D2 receptor gene locus in reward deficiency syndrome. Meta-analyses Blum K., Noble E. Handbook of Psychiatric Genetics. 1997;407-432 New York, CRC press, Boca Raton.
7. 2 dopamine receptor gene with severe alcoholism. Alcohol. 8:1991;409-416.
8. Bolos A.M., Dean M., Lucas-Derse S., Ramsburg M., Brown G.L., Goldman D. Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA. 264:1990;3156-3160.
9. Chen Chia-Hsiang, Chien Shih-Hsiang, Hwu Hai-Gwo Lack of association between TaqI A1 allele of dopamine D2 receptor gene and alcohol-use disorders in Atayal natives of Taiwan. Am J Med Genet (Neuropsych Genet). 67:1996;48-490.
10. Cravchik A., Sibley D.R., Gejman P.V. Functional analysis of the human D2 dopamine receptor missense variants. J Biol Chem. 271:1996;26013-26017.
11. Cubells J.F., Kobayashi K., Nagatsu T., Kidd K.K., Kidd J.R., Calafell F., Kranzler H., Ichinose H., Gelernter J. Population genetics of a functional variant of the dopamine β-hydroxylase gene (DBH). Am J Med Genet (Neuropsych Genet). 74:1997;374-379.
12. Easterbrook P.J., Berlin J.A., Gopalan R., Matthews D.R. Publication bias in clinical research. Lancet. 337:1991;867-872.
13. Edenberg H.J., Foroud T., Koller D.L., Goate A., Rice J., Van Eerdewegh P., Reich T., Cloninger C.R., Nurnberger J.I. Jr., Kowalczuk M., Wu B., Li T.-K., Conneally P.M., Tischfield J.A., Wu W., Shears S., Crowe R., Hesselbrock V., Schuckit M., Porjesz B., Begleiter H. A family-based analysis of the association of the dopamine D2 receptor (DRD2) with alcoholism. Alcohol Clin Exp Res. 22:1998;505-512.
14. Edwards G., Gross M.M. Alcohol dependence. Provisional description of a clinical syndrome Br Med J. 1:1976;1058-1061.
15. 2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23. Genomics. 14:1992;1010-1018.
16. Feingold A., Rounsaville B. Construct validity of the dependence syndrome as measured by DSM-IV for different psychoactive substances. Addiction. 90:1995;1661-1669.
17. 2 receptor gene in alcoholism or schizophrenia. JAMA. 271:1994;204-208.
18. Gelernter J., Kranzler H., Cubells J.F. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African and European American and Japanese populations and in alcohol dependent subjects. Human Genet. 101:1997;243-246.
19. Gelernter J., Goldman D., Risch N. The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal JAMA. 269:1993;1673-1677. a.
20. Gelernter J., Goldman D., Risch N. Alcoholism and the D2 dopamine receptor gene - Reply. (Letter). JAMA. 270:1993;1547-1548. b.
21. 2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European and African Americans. Biol Psychiatry (In press b).
22. Gelernter J., Kranzler H., Cubells J.F., Ichinose H., Nagatsu T. DRD2 allele frequencies and linkage disequilibria, including the -141CIns/Del promoter polymorphism, in European-American, African-American, and Japanese subjects. Genomics. 51:1998;21-26.
23. Gelernter J., O'Malley S., Risch N., Kranzler H., Krystal J., Merikangas K., Kennedy J., Kidd K.K. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA. 266:1991;1801-1807.
24. 2 dopamine receptor (DRD2) "A" system alleles, or DRD2 haplotypes, and posttraumatic stress disorder (PTSD). Biol Psychiatry (In press a).
25. Goldman D., Urbanek M., Guenther D., Robin R., Long J.C. Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians. Am J Med Genet. 74(4):1997;386-394.
26. Grandy D.K., Litt M., Allen L., Bunzow J.R., Marchionni M., Makam H., Reed L., Magenis R.E., Civelli O. The human dopamine D2 receptor gene is located in chromosome 11 at q22-q23 and identifies a Taq I polymorphism. Am J Hum Genet. 45:1989;778-785.
27. Hauge X.Y., Grandy D.K., Eubanks J.H., Evans G.A., Civelli O., Litt M. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics. 10:1991;527-530.
28. Hill S.Y., Locke J., Zezza N., Kaplan B., Nieswanger K., Steinhauer S.R., Wipprecht G., Xu J. Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol Psychiatry. 43:1998;40-51.
29. Kono Y., Yoneda H., Sakai T., Nonomura Y., Inayama Y., Koh J., Sakai J., Inada Y., Imamichi H., Asaba H. Association between early-onset alcoholism and the dopamine D2 receptor gene. Am J Med Genet (Neuropsychiatric Genet). 74:1997;179-182.
30. Laruelle M., Gelernter J., Innis R. D2 receptor binding potential is not affected by TaqI "A" and "B" system polymorphisms at the D2 receptor locus. Mol Psychiatry. 3:1998;261-265.
31. Lawford B.R., Young R.M., Rowell J.A., Gibson J.N., Feeney G.F., Ritchie T.L., Syndulko K., Noble E.P. Association of the D2 dopamine receptor A1 allele with alcoholism. Medical severity of alcoholism and type of controls Biol Psychiatry. 41:1997;386-393.
32. Lewontin R.C. On measures of gametic disequilibrium. Genetics. 120:1988;849-852.
33. Long J.C., Williams R.C., Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet. 56:1995;799-810.
34. 2 receptor gene in samples of female and male alcoholics. Am J Med Genet. 60:1995;267-271.
35. Noble E.P. Polymorphisms if the D2 dopamine receptor gene in alcoholism, cocaine and nicotine dependence, and obesity. Blum K., Noble E. Handbook of Psychiatric Genetics. 1997;331-351 New York, CRC press, Boca Raton.
36. Noble E.P., Syndulko K., Fitch R.J., Ritchie T., Bohlman M.C., Guth P., Sheridan P.J., Montgomery A., Heinzmann C., Sparkes R.S., Blum K. D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol & Alcoholism. 29:1994;729-744.
37. Noble E.P., Blum K., Ritchie T., Montgomery A., Sheridan P.J. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry. 48:1991;648-654.
38. Noble E.P., Berman S.M., Ozkaragoz T.Z., Ritchie T. Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. Am J Hum Genet. 54:1994;658-668.
39. Parsian A., Fisher L., O'Malley K.L., Todd R.D. A new TaqI RFLP within intron 2 of human dopamine D2 receptor gene (DRD2). Nucleic Acids Res. 19:1991;6977.
40. Pohjalainen T., Rinne J.O., Någren K., Lehikoinen P., Anttila K., Syvälahti E.K.G., Hietala J. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry. 3:1998;256-260.
41. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 59:1995;97-105.
42. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium. The insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet. 52:1993;506-516.
43. Spiess E.B. Genes in Populations. 2nd ed:1989;John Wiley and Sons, New York.
44. Spitzer R.L., Endicott J. Schedule for Affective Disorders and Schizophrenia. Lifetime Version:1975;New York State Psychiatric Institute, New York. Biometrics Research Division.
45. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R. History, rationale and description Arch Gen Psychiatry. 49:1992;624-629.
46. Stern J.M., Simes R.J. Publication bias. Evidence of delayed publication in a cohort study of clinical research projects British Med J. 315:1997;640-645.
47. Suarez B.K., Parsian A., Hampe C.L., Todd R.D., Reich T., Cloninger C.R. Linkage disequilibria at the D2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics. 19:1994;12-20.
48. Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry E.K., Morris C.M., Perry R.H., Ferrier I.N., Court J.A. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism. reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele Pharmacogenetics. 7:1997;479-484.